Page 384 - AIDSBK23C

Page 384

Jagger J. Needlestick-prevention devices: we should already be there. J Hosp Infect.
2009;71:183-184.

1072 Klatt EC. Surgery and human immunodeficiency virus infection: indications, pathologic
findings, risks, and risk prevention. Int Surg. 1994;79:1-5.

1073 Panlilio AL, Shapiro CN, Schable CA, Mendelson MH, Montecalvo MA, Kunches LM,
Perry SW 3rd, et al. Serosurvey of human immunodeficiency virus infection among
hospital-based surgeons. J Am Coll Surg. 1995;180:16-24.

1074 Goodman RA, Jenkins EL, Mercy JA. Workplace-related homicide among health care
workers in the United States, 1980 through 1990. JAMA. 1994;272:1686-1688.

1075 Department of Labor, Occupational Safety and Health Administration. Occupational
exposure to bloodborne pathogens: final rule. Federal Register. December 6,
1991;64004-64182 (29 CFR § 1910.1030).

1076 Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in
health-care facilities, 1994. MMWR. 1994;43(RR-13):1-144.

1077 Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on
inanimate surfaces? BMC Infectious Diseases. 2006;6:130-138.

1078 Terpstra FG, van den Blink AE, Bos LM, Boots AG, Brinkhuis FH, Gijsen E, van
Remmerden Y, et al. Resistance of surface-dried virus to common disinfection
procedures. J Hosp Infect. 2007;66:332-338.

1079 Sattar SA, Springthorpe VS. Survival and disinfectant inactivation of the human
immunodeficiency virus: a critical review. Rev Infect Dis. 1991;13:430-447.

1080 Tierno PM Jr. Preventing acquisition of human immunodeficiency virus in the laboratory:
safe handling of AIDS specimens. Lab Medicine. 1986;17:696-698.

1081 Orloff SL, Wallinford JC, McDougal JS. Inactivation of human immunodeficiency virus
type 1 in human milk: effects of intrinsic factors in human milk and of pasteurization. J
Human Lactation. 1993;9:13-17.

1082 Nowak T, Niedrig M, Bernhardt D, Hilfenhaus J. Inactivation of HIV, HBV, HCV
related viruses and other viruses in human plasma derivatives by pasteurization. Dev Biol
Stand. 1993;81:169-176.

1083 Cohen MS, Gay C, Kashuba AD, Blower S, Paxton L. Narrative review: antiretroviral
therapy to prevent the sexual transmission of HIV-1. Ann Intern Med. 2007;146:591-601.

1084 Roland ME. Postexposure prophylaxis after sexual exposure to HIV. Curr Opin Infect